glp 1 nejm Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment Are GLP-1 diabetes drugs like

As global demand rises for effective metabolic therapies, GLP-1 drug development remains one of the fastest-growing segments in biopharma innovation

As Houston welcomes a new GLP-1 manufacturing

Just kidding, but yes, those sulfur burps aren't just grossing you out

Semaglutide works by signaling your brain to eat less and feel fuller longer, but the duration of treatment varies by individual health goals and metabolic response

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.

The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeksin the phase one trial.